← Leaderboards
Matthias R Wabl
University Of California San Francisco
$7,929,531
Attributed
$8,138,966
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $788.6K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$8,138,966 · 6
By mechanism
R01$7,337,076 · 4
R21$801,890 · 2
Top collaborators
- Anthony L. Defranco2 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Michelle L Hermiston$3,634,874
- Anthony L. Defranco$19,534,694
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGene TargetingProteinsGenesB-LymphocytesResearch StudyMediatingTransgenic MiceImmune SystemEnzymesResponseApplications GrantsRetroviridaeGenomeComplementary DnaElementsLeadBreedingLeftBiologicalAutoimmune ProcessGene Transfer TechniquesImmunoglobulinsGene Rearrangement
Grant awards (27)
Peptides presented by DNA-specific B lymphocytes in lupus$174,350
R21 · FY2015 · AR · contact PI
Gene Targeted Mice with a Simplified Immune System$382,388
R01 · FY2014 · AI · contact PI
Peptides presented by DNA-specific B lymphocytes in lupus$208,670
R21 · FY2014 · AR · contact PI
The role of Apobec3 enzymes in regulation of marginal zone B cells$197,500
R21 · FY2014 · AI · contact PI
Gene Targeted Mice with a Simplified Immune System$359,444
R01 · FY2013 · AI · contact PI
The role of Apobec3 enzymes in regulation of marginal zone B cells$221,370
R21 · FY2013 · AI · contact PI
Gene Targeted Mice with a Simplified Immune System$382,388
R01 · FY2012 · AI · contact PI
Gene Targeted Mice with a Simplified Immune System$382,388
R01 · FY2011 · AI · contact PI
Gene Targeted Mice with a Simplified Immune System$386,250
R01 · FY2010 · AI · contact PI
Gene Targeted Mice with a Simplified Immune System$270,941
R01 · FY2010 · AI · contact PI
Gene Targeted Mice With A Simplified Immune System$317,070
R01 · FY2008 · AI · contact PI
Tumor Suppressors in Lymphocytes$265,854
R01 · FY2008 · CA · contact PI
Gene Targeted Mice With A Simplified Immune System$323,212
R01 · FY2007 · AI · contact PI
Tumor Suppressors in Lymphocytes$264,992
R01 · FY2007 · CA · contact PI
Gene Targeted Mice With A Simplified Immune System$332,865
R01 · FY2006 · AI · contact PI
Tumor Suppressors in Lymphocytes$270,687
R01 · FY2006 · CA · contact PI
Gene Targeted Mice With A Simplified Immune System$340,875
R01 · FY2005 · AI
Genetic Variation in B-Lymphocyte Ontogeny$331,875
R01 · FY2005 · AG
Gene Targeted Mice With A Simplified Immune System$340,875
R01 · FY2004 · AI
Genetic Variation in B-Lymphocyte Ontogeny$331,875
R01 · FY2004 · AG
Genetic Variation in B-Lymphocyte Ontogeny$331,875
R01 · FY2003 · AG
Genetic Variation in B-Lymphocyte Ontogeny$331,875
R01 · FY2002 · AG
GENE TARGETED MICE WITH A SIMPLIFIED IMMUNE SYSTEM$264,738
R01 · FY2002 · AI
Genetic Variation in B-Lymphocyte Ontogeny$331,875
R01 · FY2001 · AG
GENE TARGETED MICE WITH A SIMPLIFIED IMMUNE SYSTEM$257,027
R01 · FY2001 · AI
GENETIC VARIATION IN B LYMPHOCYTE ONTOGENY$283,988
R01 · FY2000 · GM
GENE TARGETED MICE WITH A SIMPLIFIED IMMUNE SYSTEM$251,719
R01 · FY2000 · AI